IPO registrations (S-1, F-1) · Registrants
BIOMARIN PHARMACEUTICAL INC
- SEC CIK
- 1048477 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 1999-05-04, last 1999-07-22; 1 initial registration, 4 amendments
- Outcome
- Final prospectus filed 1999-07-26
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 105 DIGITAL DRIVE, Novato, CA 94949
- EIN
- 68-0397820
- Ticker
- BMRN (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- BIOMARIN PHARMACEUTICAL INC on the corporate pages
Offering terms
- Final price
- $13.00 per share (424B4 filed 1999-07-26, an initial public offering)
- Shares sold
- 4,500,000
- Gross proceeds
- $58,500,000 before underwriting discounts and any over-allotment option
- Lead underwriters
- Piper Sandler
- Syndicate
- Leerink Partners (60,000); Bank J. Vontobel & Co AG (540,000); Schroders & Co. Inc (185,000); BofA Securities (50,000); Robertson Stephens (50,000); Oppenheimer (50,000); A.G. Edwards (50,000); Lehman Brothers (50,000); Prudential Securities (50,000); Cowen (50,000); EVEREN Securities, Inc (25,000); Janney Montgomery Scott (25,000); Legg Mason (25,000); Stephens (25,000); First Security Van Kesper (25,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: BIOMARIN PHARMACEUTICAL INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: BIOMARIN PHARMACEUTICAL INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: BioMarin Pharmaceutical Inc. Fuzzy (name and state)
- Business registration: BioMarin Pharmaceutical Inc. Fuzzy (name and state)
- Business registration: BioMarin Pharmaceutical Inc. Fuzzy (name and state)
- Business registration: BioMarin Pharmaceutical Inc. Fuzzy (name and state)
- Business registration: BIOMARIN PHARMACEUTICAL Inc. Fuzzy (name and state)
- Business registration: BIOMARIN PHARMACEUTICAL INC. Fuzzy (name and state)
- Business registration: BIOMARIN PHARMACEUTICAL INC. Fuzzy (name and state)
- Business registration: BIOMARIN PHARMACEUTICAL INC. Fuzzy (name and state)
- Form 5500 plan sponsor: BIOMARIN PHARMACEUTICAL INC. EXACT (EIN (EXACT))
- Political committee (FEC): BIOMARIN PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE AKA BIOMARIN PAC (connected to BIOMARIN PHARMACEUTICAL INC.) Fuzzy (name and state)
- Federal award recipient: BIOMARIN PHARMACEUTICAL INC Fuzzy (name and state)
- Lobbying client: BIOMARIN PHARMACEUTICAL INC Fuzzy (name and state)
- Lobbying client: BIOMARIN PHARMACEUTICAL INC. Fuzzy (name and state)
- Lobbying client: BIOMARIN PHARMACEUTICAL INC. Fuzzy (name and state)
- Lobbying client: BIOMARIN PHARMACEUTICAL INC. Fuzzy (name and state)
- Lobbying client: BIOMARIN PHARMACEUTICAL INC. Fuzzy (name and state)
- Lobbying client: BIOMARIN PHARMACEUTICAL INC. Fuzzy (name and state)
- Lobbying client: BIOMARIN PHARMACEUTICAL, INC. Fuzzy (name and state)
- Lobbying client: BIOMARIN PHARMACEUTICAL, INC. Fuzzy (name and state)
- Lobbying client: BIOMARIN PHARMACEUTICAL, INC. Fuzzy (name and state)
- Lobbying registrant: BIOMARIN PHARMACEUTICAL INC. Fuzzy (name and state)
- SEC filer: BIOMARIN PHARMACEUTICAL INC EXACT (CIK (EXACT))
- Person page: Robert M Plenge Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Timothy P Walbert Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 6
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1999-05-04 | S-1 | S-1 (registration) | BIOMARIN PHARMACEUTICAL INC | 0000898430-99-001840 ↗ |
| 1999-06-14 | S-1/A | S-1/A (amendment) | BIOMARIN PHARMACEUTICAL INC | 0001012870-99-001932 ↗ |
| 1999-07-06 | S-1/A | S-1/A (amendment) | BIOMARIN PHARMACEUTICAL INC | 0001012870-99-002193 ↗ |
| 1999-07-21 | S-1/A | S-1/A (amendment) | BIOMARIN PHARMACEUTICAL INC | 0001012870-99-002419 ↗ |
| 1999-07-22 | S-1/A | S-1/A (amendment) | BIOMARIN PHARMACEUTICAL INC | 0000950109-99-002584 ↗ |
| 1999-07-26 | 424B4 | 424B4 (final prospectus) | BIOMARIN PHARMACEUTICAL INC | 0001012870-99-002512 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1999-07-22 | S-1/A | registration statement | $4.68 | 4,500,000 | $21,060,000 | 2 | from the submission text; price line, shares headline, proceeds computed, cover names 2 | document ↗ | ||
| 1999-07-26 | 424B4 | final prospectus | $13.00 | 4,500,000 | $58,500,000 | 16 | from the submission text; price sentence, shares headline, proceeds table, underwriting table 15, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BIENAIME JEAN JACQUES | Director; Director,Officer; Officer | Chief Business Officer; Chief Executive Office; Chief Executive Officer | 365 | 2006–2024 | |
| SAGER ERICH | Director | 5 | 2006 | ||
| ASELAGE STEVE | Officer | EVP, Chief Business Officer; SVP, Chief Business Officer; SVP, Global Commercial Dev; SVP, Global Commercial Dev.; SVP, Global Commercial Ops | 40 | 2006–2012 | |
| BAFFI ROBERT | Officer | EVP, Technical Operations; President, Global Mfg/Tech Ops; SVP, Commercial Operations; SVP, Technial Operations; SVP, Technical Operations; SVP, Technical Operatons | 101 | 2006–2020 | |
| Cooper Jeffrey H | Officer | Chief Financial Officer; SVP, Chief Financial Officer; VP, Chief Financial Officer | 44 | 2006–2012 | |
| KAKKIS EMIL D | Officer | Chief Medical officer; Chief Medical Officer; CHIEF MEDICAL OFFICER; SVP, Chief Medical Officer | 26 | 2006–2009 | |
| Swiedler Stuart J | Officer | SVP, Clinical Affairs | 16 | 2006–2008 | |
| LAPALME PIERRE | Director | 23 | 2006–2015 | ||
| CRISTIANI FRANZ L | Director | 1 | 2006 | ||
| HERON ELAINE J | Director | 36 | 2006–2024 | ||
| KLEIN JOSEPH III | Director | 14 | 2006–2010 | ||
| LEWIS ALAN | Director | 25 | 2006–2019 | ||
| Davis George Eric | Officer | EVP, Chief Legal Officer; EVP, General Counsel; SVP, Chief Commercial Of; SVP, General Counsel; VP, General Counsel | 153 | 2006–2026 | |
| GREY MICHAEL G | Director | 26 | 2006–2021 | ||
| MEIER RICHARD A | Director | 43 | 2006–2026 | ||
| Wood Mark | Officer | VP, Human Resources | 95 | 2007–2013 | |
| LAWLIS V BRYAN | Director | 48 | 2007–2023 | ||
| FUCHS HENRY J | Officer | Chief Medical Officer; EVP, Chief Medical Officer; President, Worldwide R&D | 123 | 2009–2024 | |
| BATE KENNETH | Director | 7 | 2010–2015 | ||
| YOUNG WILLIAM D | Director | 7 | 2010–2015 | ||
| Mueller Brian | Officer | EVP, Chief Financial Officer; SVP, Acting CFO; SVP, Corporate Controller; SVP, Finance and CAO; VP, Corporate Controller | 96 | 2011–2026 | |
| SPIEGELMAN DANIEL K | Officer | EVP, Chief Financial Officer | 66 | 2012–2019 | |
| Ajer Jeffrey Robert | Officer | EVP, Chief Commercial Officer; SVP, Chief Commercial Of; SVP, Chief Commercial Officer | 112 | 2012–2024 | |
| Slamon Dennis | Director | 14 | 2014–2024 | ||
| PYOTT DAVID E I | Director | 12 | 2016–2024 | ||
| Dere Willard H | Director | 14 | 2016–2026 | ||
| FALBERG KATHRYN E | Director | 3 | 2016 | ||
| HOMBACH ROBERT J. | Director | 11 | 2017–2026 | ||
| ANDERSON ELIZABETH M | Director | 9 | 2019–2026 | ||
| Guyer Charles Greg | Officer | EVP, Chief Technical Officer | 26 | 2020–2026 | |
| Acosta Andrea | Officer | GVP, Chief Accouning Officer; GVP, Chief Accounting Officer | 5 | 2020–2021 | |
| Ho Maykin | Director | 8 | 2021–2026 | ||
| Alles Mark J | Director | 5 | 2022–2023 | ||
| Burkhart Erin | Officer | GVP, Chief Accounting Officer | 12 | 2022–2025 | |
| Hardy Alexander | Director,Officer | Chief Executive Officer | 8 | 2023–2026 | |
| Bodem Barbara W. | Director | 5 | 2023–2026 | ||
| Countouriotis Athena | Director | 5 | 2023–2026 | ||
| Enyedy Mark J | Director | 5 | 2023–2026 | ||
| Hubbard Cristin | Officer | EVP, Chief Commercial Officer | 8 | 2024–2026 | |
| Friberg Gregory R | Officer | EVP, Chief R&D Officer | 8 | 2024–2026 | |
| Walbert Timothy P | Director | 5 | 2025–2026 | person page Fuzzy | |
| CLARK IAN T | Director | 3 | 2025–2026 | ||
| Ramchandani Rashmi Virendra | Officer | VP, Chief Accounting Officer | 2 | 2026 | |
| Plenge Robert M | Director | 2 | 2026 | person page Fuzzy |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | BioMarin Pharmaceutical Inc. | CA | State business registries | name and state |
| Business registration | BioMarin Pharmaceutical Inc. | CA | State business registries | name and state |
| Business registration | BioMarin Pharmaceutical Inc. | CA | State business registries | name and state |
| Business registration | BioMarin Pharmaceutical Inc. | CA | State business registries | name and state |
| Business registration | BIOMARIN PHARMACEUTICAL Inc. | CA | State business registries | name and state |
| Business registration | BIOMARIN PHARMACEUTICAL INC. | CA | State business registries | name and state |
| Business registration | BIOMARIN PHARMACEUTICAL INC. | CA | State business registries | name and state |
| Business registration | BIOMARIN PHARMACEUTICAL INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | BIOMARIN PHARMACEUTICAL INC. | CA | State business registries | name and state |
| Business registration | BIOMARIN PHARMACEUTICAL INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Political committee | BIOMARIN PHARMACEUTICAL INC. POLITICAL ACTION COMMITTEE AKA BIOMARIN PAC (connected to BIOMARIN PHARMACEUTICAL INC.) | CA | Campaign finance (FEC) | name and state |
| Federal award recipient | BIOMARIN PHARMACEUTICAL INC | CA | Federal spending (USAspending) | name and state |
| Lobbying client | BIOMARIN PHARMACEUTICAL INC | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | BIOMARIN PHARMACEUTICAL INC. | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | BIOMARIN PHARMACEUTICAL INC. | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | BIOMARIN PHARMACEUTICAL INC. | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | BIOMARIN PHARMACEUTICAL INC. | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | BIOMARIN PHARMACEUTICAL INC. | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | BIOMARIN PHARMACEUTICAL, INC. | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | BIOMARIN PHARMACEUTICAL, INC. | CA | Federal lobbying (LDA) | name and state |
| Lobbying client | BIOMARIN PHARMACEUTICAL, INC. | CA | Federal lobbying (LDA) | name and state |
| Lobbying registrant | BIOMARIN PHARMACEUTICAL INC. | CA | Federal lobbying (LDA) | name and state |
| Paying company | BioMarin Pharmaceutical Inc. | CA | Open Payments (drug and device company payments) | name and state |
| Nonprofit | TOASTMASTERS INTERNATIONAL | CA | Nonprofits (IRS Form 990) | same street address and ZIP code, 105 DIGITAL DR 94949 (FUZZY: a shared address, not proof of a shared organization) |
| Patent assignee | BIOMARIN PHARMACEUTICAL INC. | CA | Patents (USPTO) | name and state |
| SEC filer | BIOMARIN PHARMACEUTICAL INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Biomarin Pharmaceutical Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | BIOMARIN PHARMACEUTICAL INC. | EIN (EXACT) | ||
| Person page | Robert M Plenge | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Timothy P Walbert | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CA first:
- CONNETICS CORP CA
- SIBIA NEUROSCIENCES INC CA
- MEDIVATION, INC. CA
- IMMUSOL INC CA
- DYNAVAX TECHNOLOGIES CORP CA
- RIGEL PHARMACEUTICALS INC CA
- Diadexus, Inc. CA
- CymaBay Therapeutics, Inc. CA
- CRESCENDO PHARMACEUTICALS CORP CA
- SPIROS DEVELOPMENT CORP II INC CA
In other datasets, the same topic (Health) in CA:
- Nonprofit: 24 HOUR CANCER DANCE-A-THON (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health